Upstream Bio, Inc.
UPB
$8.95
-$0.16-1.76%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 668.00K | 683.00K | 937.00K | 566.00K | 613.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 668.00K | 683.00K | 937.00K | 566.00K | 613.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 668.00K | 683.00K | 937.00K | 566.00K | 613.00K |
| SG&A Expenses | 6.67M | 5.54M | 7.42M | 6.78M | 5.16M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 46.84M | 38.52M | 45.28M | 32.58M | 26.93M |
| Operating Income | -46.17M | -37.83M | -44.35M | -32.01M | -26.32M |
| Income Before Tax | -42.46M | -33.75M | -39.97M | -27.27M | -21.24M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -42.46M | -33.75M | -39.97M | -27.27M | -21.24M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -42.46M | -33.75M | -39.97M | -27.27M | -21.24M |
| EBIT | -46.17M | -37.83M | -44.35M | -32.01M | -26.32M |
| EBITDA | -46.11M | -37.79M | -44.31M | -31.97M | -26.27M |
| EPS Basic | -0.79 | -0.63 | -0.74 | -0.51 | -0.76 |
| Normalized Basic EPS | -0.49 | -0.39 | -0.46 | -0.32 | -0.29 |
| EPS Diluted | -0.79 | -0.63 | -0.74 | -0.51 | -0.76 |
| Normalized Diluted EPS | -0.49 | -0.39 | -0.46 | -0.32 | -0.29 |
| Average Basic Shares Outstanding | 54.09M | 53.93M | 53.77M | 53.62M | 45.70M |
| Average Diluted Shares Outstanding | 54.09M | 53.93M | 53.77M | 53.62M | 45.70M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |